NNOX - 2 Soaring Growth Stocks That Could Rocket Even Higher
2023-05-16 05:41:00 ET
So far, 2023 is turning out to be a pretty good year for growth stock investors in general. The Vanguard Growth ETF has already gained 19% in 2023.
For investors with either CRISPR Therapeutics (NASDAQ: CRSP) or Nanox (NASDAQ: NNOX) in their portfolios, it's already been a great year. Shares of both stocks are way up recently. They've risen for straightforward reasons, but there are a few things you should know before trying to ride their momentum higher.
Shares of CRISPR Therapeutics are up more than 57% since the end of 2022. This is still a clinical-stage business that doesn't have any products to sell yet.
For further details see:
2 Soaring Growth Stocks That Could Rocket Even Higher